您的位置: 首页 > 农业专利 > 详情页

DÉRIVÉ DE 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE ET SON APPLICATION MÉDICALE
专利权人:
Sumitomo Dainippon Pharma Co.; Ltd.
发明人:
申请号:
EP18882052.6
公开号:
EP3719023A1
申请日:
2018.11.22
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
Provided are a compound that is useful for the prevention of and/or as a treatment agent for a disease in which a group II mGlu receptor is involved; and a medical application of said compound. Provided is a compound repesented by formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, R1 and R2 independently represent a hydrogen atom, a C1-4 alkyl or the like; ring A represents a C6-10 aromatic carbon ring group, a 4 to 10 membered saturated heterocyclic group or the like; R3 and R4 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl, a C1-4 alkoxy or the like; R5 and R6 independently represent a hydrogen atom, a C1-6 alkyl, a C1-6 alkoxy, an-NRaRb or the like; Ra and Rb independently represent a hydrogen atom, a C1-4 alkyl or the like; X represents a nitrogen atom or a -CRe-; and Re represents a hydrogen atom, a halogen atom, a C1-6 alkyl or the like).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充